Prescription GLP-1 therapy considered only for eligible patients after medical evaluation, contraindication screening and an honest conversation about fit.
Prescription GLP-1 receptor agonist therapy, considered only for eligible patients after a real medical evaluation, contraindication screening and a shared decision-making conversation, not a script handed out on request.
The medication works on appetite-regulating pathways, prescribed and dosed by the evaluating clinician based on your individual health profile.
The process starts with an in-person medical evaluation, history review and any needed labs, before any prescribing decision is made. The visit itself runs about 30 to 60 minutes.
Ongoing monitoring is part of the plan, not an afterthought, follow-up visits track response and adjust the plan as needed.
Results vary by individual, adherence and clinical factors, we do not promise a specific number on the scale, only a supervised, evidence-based path.
Not appropriate for every patient, certain medical histories rule it out, and we will tell you plainly if that is your case rather than prescribe around it.
Only eligible patients after a real medical evaluation, contraindication screening and a shared decision-making conversation, not a script handed out on request.
An in-person medical evaluation, history review and any needed labs, before any prescribing decision is made.
Yes, ongoing monitoring is part of the plan, not an afterthought; follow-up visits track response and adjust the plan.
No, results vary by individual, adherence and clinical factors; we do not promise a specific number on the scale, only a supervised, evidence-based path.
No, it is not appropriate for every patient, certain medical histories rule it out, and we will tell you plainly if that is your case.
Book a private consultation and let us build a plan that is right for you.
Book a Consultation